Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.868
-0.022 (-2.46%)
At close: Apr 28, 2026, 4:00 PM EDT
0.850
-0.018 (-2.04%)
Pre-market: Apr 29, 2026, 7:50 AM EDT
RANI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 1.63 | 1.03 | - | - | 2.72 | |
| Revenue Growth (YoY) | 58.85% | - | - | - | 488.10% | |
| Gross Profit | 1.63 | 1.03 | - | - | 2.72 | |
| Selling, General & Admin | 19.74 | 23.95 | 26.48 | 26.84 | 27.83 | |
| Research & Development | 20.21 | 26.68 | 39.62 | 36.61 | 26.48 | |
| Operating Expenses | 39.94 | 50.63 | 66.1 | 63.45 | 54.32 | |
| Operating Income | -38.31 | -49.6 | -66.1 | -63.45 | -51.6 | |
| Interest Expense | -2.89 | -5.03 | -5.09 | -1.07 | -0.47 | |
| Interest & Investment Income | 0.83 | 1.76 | 3.3 | 1.25 | 0.09 | |
| Other Non Operating Income (Expenses) | - | - | - | - | -0.37 | |
| EBT Excluding Unusual Items | -40.37 | -52.87 | -67.88 | -63.27 | -52.35 | |
| Asset Writedown | - | -3.71 | - | - | - | |
| Other Unusual Items | -0.58 | - | - | - | -0.7 | |
| Pretax Income | -40.95 | -56.58 | -67.88 | -63.27 | -53.05 | |
| Income Tax Expense | - | - | - | 0.07 | 0.04 | |
| Earnings From Continuing Operations | -40.95 | -56.58 | -67.88 | -63.34 | -53.09 | |
| Minority Interest in Earnings | 11.28 | 26.57 | 33.91 | 32.76 | 44.76 | |
| Net Income | -29.67 | -30.02 | -33.97 | -30.59 | -8.33 | |
| Net Income to Common | -29.67 | -30.02 | -33.97 | -30.59 | -8.33 | |
| Shares Outstanding (Basic) | 66 | 28 | 26 | 24 | 20 | |
| Shares Outstanding (Diluted) | 66 | 28 | 26 | 24 | 20 | |
| Shares Change (YoY) | 132.26% | 11.65% | 7.09% | 21.93% | -58.34% | |
| EPS (Basic) | -0.45 | -1.05 | -1.33 | -1.28 | -0.43 | |
| EPS (Diluted) | -0.45 | -1.05 | -1.33 | -1.28 | -0.43 | |
| Free Cash Flow | -18.8 | -35.76 | -52.47 | -48.13 | -32.75 | |
| Free Cash Flow Per Share | -0.28 | -1.26 | -2.06 | -2.02 | -1.68 | |
| Gross Margin | 100.00% | 100.00% | - | - | 100.00% | |
| Operating Margin | -2345.99% | -4824.90% | - | - | -1899.12% | |
| Profit Margin | -1817.09% | -2920.04% | - | - | -306.63% | |
| Free Cash Flow Margin | -1151.38% | -3478.99% | - | - | -1205.41% | |
| EBITDA | -37.41 | -48.57 | -65.28 | -62.9 | -51.1 | |
| D&A For EBITDA | 0.9 | 1.03 | 0.82 | 0.55 | 0.5 | |
| EBIT | -38.31 | -49.6 | -66.1 | -63.45 | -51.6 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.